Glen Harbor Capital Management LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Glen Harbor Capital Management LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2019$167,000
-8.2%
3,4540.0%0.00%
-25.0%
Q2 2019$182,000
-13.3%
3,454
-12.8%
0.00%
-20.0%
Q1 2019$210,000
-25.0%
3,960
-41.9%
0.01%
-28.6%
Q4 2018$280,000
+536.4%
6,820
+604.5%
0.01%
+600.0%
Q2 2018$44,0009680.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 460,000$14,872,00013.19%
VHCP Management II, LLC 141,611$4,578,0003.76%
Perceptive Advisors 1,186,630$38,363,0002.84%
RTW INVESTMENTS, LP 175,156$5,663,0001.87%
Casdin Capital, LLC 65,000$2,101,0001.86%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,163,811$37,626,0001.52%
RA Capital Management 457,142$14,779,0001.46%
VHCP Management, LLC 60,691$1,962,0001.19%
Iguana Healthcare Management, LLC 110,000$3,556,0001.17%
Partner Investment Management, L.P. 15,634$505,0000.83%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders